Soleus Capital Management’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,000
| Closed | -$598K | – | 95 |
|
|
2025
Q1 | $598K | Sell |
16,000
-54,000
| -77% | -$2.02M | 0.04% | 72 |
|
|
2024
Q4 | $3.17M | Buy |
+70,000
| New | +$3.17M | 0.2% | 61 |
|
|
2024
Q2 | – | Sell |
-20,000
| Closed | -$1.33M | – | 94 |
|
|
2024
Q1 | $1.33M | Sell |
20,000
-15,000
| -43% | -$997K | 0.1% | 78 |
|
|
2023
Q4 | $978K | Hold |
35,000
| – | – | 0.11% | 62 |
|
|
2023
Q3 | $746K | Buy |
+35,000
| New | +$746K | 0.07% | 82 |
|